[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367286-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367286-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","harnessing-the-power-of-metabolomics-for-precision-oncology-current-advances-and-future-directions","Harnessing the Power of Metabolomics for Precision Oncology: Current Advances and Future Directions","","Metabolic reprogramming drives cancer growth, with malignant cells adopting distinct metabolic traits and exhibiting extensive intra- and inter-tumour metabolic heterogeneity. Decoding these metabolic features creates opportunities for precision diagnosis and therapy, yet metabolic phenotyping lags behind genetic, transcriptomic, and immunohistochemical profiling in clinical use. The gap reflects the absence of a single method that profiles the entire metabolome, requiring multiple complementary technologies to capture metabolic plasticity. This review surveys available tools, illustrates preclinical and clinical applications, and highlights how metabolomic profiling can be integrated with other omics to inform tumour biology and treatment decisions.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/harnessing-the-power-of-metabolomics-for-precision-oncology-current-advances-and-future-directions/367286/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/harnessing-the-power-of-metabolomics-for-precision-oncology-current-advances-and-future-directions/367286.png","ImageObject",300,407,{"name":42,"@type":43},"Aurelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why does metabolomics have strong potential in precision oncology?","Question",{"text":63,"@type":64},"Cancer cells rely on metabolic reprogramming and show metabolic heterogeneity, so metabolic features can support more precise diagnostic and therapeutic decisions. Non-invasive metabolic profiling can detect and monitor tumour progression, and metabolic biomarkers may reflect altered signalling pathways across subtypes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What limits clinical adoption of metabolic phenotyping?",{"text":68,"@type":64},"There is no single experimental technique capable of profiling the entire metabolome at once. As a result, researchers must combine multiple technologies, making comprehensive metabolic biomarker identification more challenging.",{"name":70,"@type":61,"acceptedAnswer":71},"Which technologies does the review emphasize for studying tumour metabolism?",{"text":72,"@type":64},"The review focuses on the repertoire of tools used to profile cancer metabolism, starting from metabolomics as a set of analytical chemical techniques. It also discusses integrating metabolomic profiling with other omics approaches to gain insights into tumour biology and guide treatment strategies.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367286,1790870157,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Review  \nHarnessing the Power of Metabolomics for Precision Oncology: Current Advances and Future Directions  \nManas Kohli  and George Poulogiannis *  \nSignalling and Cancer Metabolism Laboratory, Division of Cell and Molecular Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK; [manas.kohli@icr.ac.uk](manas.kohli@icr.ac.uk)  \n* Correspondence: [george.poulogiannis@icr.ac.uk](george.poulogiannis@icr.ac.uk)  \nAbstract: Metabolic reprogramming is a hallmark of cancer, with cancer cells acquiring many unique metabolic traits to support malignant growth, and extensive intra-and intertumour metabolic heterogeneity. Understanding these metabolic characteristics presents opportunities in precision medicine for both diagnosis and therapy. However, despite its potential, metabolic phenotyping has lagged behind genetic, transcriptomic, and immunohistochemical profiling in clinical applications. This is partly due to the lack of a single experimental technique capable of profiling the entire metabolome, necessitating the use of multiple technologies and approaches to capture the full range of cancer metabolic plasticity. This review examines the repertoire of tools available for profiling cancer metabolism, demonstrating their applications in preclinical and clinical settings. It also presents case studies illustrating how metabolomic profiling has been integrated with other omics technologies to gain insights into tumour biology and guide treatment strategies. This information aims to assist researchers in selecting the most effective tools for their studies and highlights the importance of combining different metabolic profiling techniques to comprehensively understand tumour metabolism.  \nAcademic Editor: Tommaso Mello  \nReceived: 25 November 2024  \nRevised: 24 February 2025  \nAccepted: 7 March 2025  \nPublished: 10 March 2025  \nCitation: Kohli, M.; Poulogiannis, G. Harnessing the Power of Metabolomics for Precision Oncology:  \nCurrent Advances and Future Directions. Cells 2025, 14, 402 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)cells14060402  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \nKeywords: metabolomics; cancer; precision medicine; therapy; metabolome  \n1. Introduction  \nMetabolic reprogramming is undoubtedly one of the crucial hallmarks of cancer pathogenesis [1] . Tumour cells undergo several metabolic adaptations, often in a nutrientdeficient microenvironment, to sustain their increased rate of growth and proliferation [2] . Perhaps the most well-known example of cancer metabolic reprogramming is the ‘Warburg effect’, which refers to the tumour cells’ preference for using glycolysis even in the presence of oxygen (aerobic glycolysis) [3] . However, the switch from aerobic cellular respiration to aerobic glycolysis represents just the tip of the iceberg, and cancer cells acquire many other unique metabolic traits to support their malignant growth, including enhanced generation of antioxidant and detoxification capacity, upregulation of lipid metabolism or addiction to glutamine metabolism [4] . Tumours further display extensive intra and inter-tumour metabolic heterogeneity which is manifested in both spatial and temporal dimensions [5] .  \nUnderstanding the metabolic characteristics and dependencies of cancer cells presents several opportunities in precision medicine from both a diagnostic and therapeutic perspective. Non-invasive metabolic profiling has been routinely applied to accurately detect and monitor tumour progression, whilst metabolic biomarkers show immense promise in identifying altered signalling pathways associated with specific cancer subtypes [6] . Desp","cbCaiqsH8sAhRsTr","https://ap.wps.com/l/cbCaiqsH8sAhRsTr","pdf",1724471,26,"English","# Introduction\n# An Overview of Technologies and Approaches in Studying Tumour Metabolism","[{\"question\":\"Why does metabolomics have strong potential in precision oncology?\",\"answer\":\"Cancer cells rely on metabolic reprogramming and show metabolic heterogeneity, so metabolic features can support more precise diagnostic and therapeutic decisions. Non-invasive metabolic profiling can detect and monitor tumour progression, and metabolic biomarkers may reflect altered signalling pathways across subtypes.\"},{\"question\":\"What limits clinical adoption of metabolic phenotyping?\",\"answer\":\"There is no single experimental technique capable of profiling the entire metabolome at once. As a result, researchers must combine multiple technologies, making comprehensive metabolic biomarker identification more challenging.\"},{\"question\":\"Which technologies does the review emphasize for studying tumour metabolism?\",\"answer\":\"The review focuses on the repertoire of tools used to profile cancer metabolism, starting from metabolomics as a set of analytical chemical techniques. It also discusses integrating metabolomic profiling with other omics approaches to gain insights into tumour biology and guide treatment strategies.\"}]","Harnessing the Power of Metabolomics for Precision Oncology: Current Advances and Future Directions | PDF",1790170090,66,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/732c9f1d573e1909b8f96738f2f70c27.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2b0ad72ec2f06a55fa95968d5e43f26.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de2f2b4380e2f499b6932032fe0c9677.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45c4701890eb443fa8eec1dba1ed4ec7.webp",980,1385]